Eisai seeks approval for antiepileptic agent in Japan

Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 1 Comment | 31 Aug, 2012

Singapore: Eisai has submitted a marketing authorization application to Japan's Ministry of Health, Labor and Welfare (M...Read more

Bayer progresses on APAC hepatocellular carcinoma trial

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 11 Jun, 2013

Singapore: GIDEON (Global Investigation of therapeutic Decisions in hepatocellular carcinoma and of its treatment with s...Read more

Cipla malaria drug gets WHO pre-qualification

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 04 Oct, 2012

Mumbai: Cipla along with the non-profit R&D organization, Drugs for Neglected Diseases initiative (DNDi), revealed t...Read more

Boston Strategics gets rights for Eisai's cancer drug

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 10 Jul, 2014

Singapore: Boston Strategics Corp (BSC), a clinical-stage drug research and development (R&D) company has signed an ...Read more

Activation of mTorc1 causes colon, gastric cancers

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 22 Jan, 2013

Singapore: Associate Professor Matthias Ernst and colleagues from Australia's Walter and Eliza Hall Institute have ident...Read more

ASLAN announces global license agreement with Almirall

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 21 May, 2012

Singapore: ASLAN Pharmaceuticals has obtained the global rights to Almirall's DHODH inhibitor, LAS186323, currently in p...Read more

Ian Frazer gets $200k to make HPV DNA vaccine

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 20 Dec, 2012

Singapore: Professor Ian Frazer and his team at the University of Queensland, have been awarded grant from Australia's N...Read more

South Korea firm emerges as R&D force

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 12 Apr, 2012

According to the Global Burden of Disease and Risk Factors (World Bank Publications, 2006), infectious diseases are one ...Read more

FDA offers guidance on Alzheimer's drug development

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 08 Feb, 2013

Singapore: The US Food and Drug Administration has issued a proposal designed to assist companies developing new treatme...Read more

Zydus initiates Ph III trial of Lipaglyn for lipodystrophy

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 02 Jun, 2014

Singapore: India based drug company, Zydus, has initiated Phase III trials of Lipaglyn (Saroglitazar) to evaluate its sa...Read more

Australian firm gets rights to Anamorelin

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 15 Oct, 2012

Singapore: Melbourne-based biopharmaceutical company Specialised Therapeutics Australia (STA) has been granted exclusive...Read more

3SBio acquires patents for kidney failure drug

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 31 Oct, 2013

Singapore: China-based 3SBio, which is focused on R&D, manufacturing and marketing biopharmaceutical products, acqu...Read more

Glenmark's MAb drug enters human trials

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 04 Jul, 2014

Singapore: Glenmark Pharmaceuticals, a research-driven, global integrated pharmaceutical company announced that its nove...Read more

Avantor launches polysorbates for pharma

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 11 Sep, 2013

Singapore: US-based Avantor Performance Materials has introduced a higher purity Super Refined grade of polysorbate prod...Read more

Novartis pledges to eliminate leprosy

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 02 Dec, 2013

Singapore: Novartis Foundation for Sustainable Development (NFSD) has launched a new leprosy strategy focused on interru...Read more

AstraZeneca begins cancer research in Russia

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 15 Feb, 2013

Singapore: AstraZeneca and NN Petrov Institute of Oncology, one of Russia's leading cancer research institutions, signed...Read more

Tachycardia holds room to grow: Report

Drug Discovery |  Analysis | By BioSpectrum Bureau  | 0 Comment | 03 Aug, 2012

Singapore: A rapid heart rate is a common condition among elderly individuals, and represents a potential goldmine for p...Read more

ETC, AstraZeneca form drug R&D partnership

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 05 Nov, 2013

Singapore: Experimental Therapeutics Center (ETC) and Exploit Technologies of Agency for Science, Technology and Researc...Read more